Successful Use of Recombinant Activated Factor VII for Trauma-Associated Hemorrhage in a Patient without Preexisting Coagulopathy
- 1 February 2002
- journal article
- case report
- Published by Wolters Kluwer Health
- Vol. 52 (2), 400-405
- https://doi.org/10.1097/00005373-200202000-00034
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VIIThe American Journal of Medicine, 2000
- Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulationBlood Coagulation & Fibrinolysis, 2000
- Massive blood transfusion exceeding 50 units of plasma poor red cells or whole blood: the survival rate and the occurrence of leukopenia and acidosisInjury, 1999
- SUCCESSFUL USE OF RECOMBINANT FVIIa (NOVOSEVEN®) IN THE MANAGEMENT OF PULMONARY HAEMORRHAGE SECONDARY TO ASPERGILLUS INFECTION IN A PATIENT WITH LEUKAEMIA AND ACQUIRED FVII DEFICIENCYBritish Journal of Haematology, 1999
- Clinical picture and treatment strategies in factor VII deficiencyHaemophilia, 1998
- Replacement of Massive Blood LossVox Sanguinis, 1998
- Treatment of a Patient with Bernard-Soulier Syndrome and Recurrent Nosebleeds with Recombinant Factor VIIaThrombosis and Haemostasis, 1998
- Clinical update on the use of recombinant factor VIIPublished by Springer Nature ,1995
- Acquired haemophilia in association with Type III von Willebrandʼs diseaseBlood Coagulation & Fibrinolysis, 1993
- Therapeutic Concentrates for the Treatment of Congenital Deficiencies of Factors VII, XI, and XIIISeminars in Thrombosis and Hemostasis, 1993